Operations Contingency in Relation to Coronavirus (COVID-19)
In line with the current United Kingdom Government advice regarding the Corona Virus (COVID-19), TRB Chemedica (UK) Ltd have adopted all recommended measures to prevent the transmission and spread of the disease.
Essential Head Office staff have been advised to self-monitor and report on a continual basis if they are feeling unwell, or manifesting symptoms. Non-essential Head Office staff will be working remotely, with full access to all systems. Non-essential meetings with external commercial partners and colleagues at our Head Office are cancelled until further notice. Delivery and collection interactions will be conducted in line with the advice on reduced contact and personnel separation recommendations.
All Sales Team appointments at hospital and GP surgery sites that have announced restricted industry access have been postponed. All training and non-essential staff meetings at Head Office have also been re-scheduled.
Enhanced hygiene and sterility measures throughout the Head Office premises have been adopted, with work surface and common access contact points undergoing regular sterile wipe cleansing.
TRB Chemedica (UK) Ltd have ample stocks of all our product lines, and there is no likelihood of any product shortages, and our production and logistics lines are assured.
Please also visit our Ostenil website for more information on NHS guidelines on corticosteroid injections during the pandemic: https://ostenil.trbchemedica.co.uk/business-professionals/viscosupplements-an-alternative-to-steroid-injections
Your Team at
TRB Chemedica (UK) Ltd